Results 131 to 140 of about 51,459 (306)

Adjuvant Mood Stabilisers for Long-Term Management of Treatment-Resistant Schizophrenia: A Case Report. [PDF]

Cureus
Anyameluhor F, Elliott C.
europepmc   +1 more source

Use of the booklet category test to assess abstract concept formation in schizophrenic disorders [PDF]

, 2012
Boyle, Gregory J., Steindl, Stanley R.
core  

Associations of cannabis use, tobacco use and co‐use with brain volume: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer, Tom P. Freeman, Martine Skumlien, Esther Walton, Thomas Lancaster, Jorien L. Treur, Valentina Lorenzetti, Anna K. M. Blackwell, Chloe Burke, Richie J. Carr, Constantinos Constantinides, Maisie Cox, Sarah Dance, Shadi Daryan, Sorcha Hamilton, Tom Jenkins, Gemma M. J. Taylor   +16 more
wiley   +1 more source

How researchers refer to individuals with schizophrenia: person-first and identity-first language in academic papers. [PDF]

Schizophrenia (Heidelb)
Dino M, Koga G, Yokoji A, Haguiara B, Pacheco I, Ziebold C, Bressan R, Crossley N, Orsi J, Thornicroft G, Slade M, Mari JJ, Evans-Lacko S, Andrade MCR, Gadelha A.   +14 more
europepmc   +1 more source

Changes over time in hallucinogen‐related emergency department visits in Ontario, Canada

Addiction, EarlyView.
Abstract Background and aims Recent increasing interest in hallucinogens has underscored the critical gaps in our understanding of their adverse health effects and healthcare usage over time. The current study aimed to examine changes in emergency department (ED) visit rates involving hallucinogens, clinical outcomes of visits and the characteristics ...
Daniel T. Myran, Rachael MacDonald‐Spracklin, Alexander R. Levesque, Michael Pugliese, Jess G. Fiedorowicz, André J. McDonald, Joshua D. Rosenblat, Ian Colman, Josephine Zein, Marco Solmi   +9 more
wiley   +1 more source

Stress, coping strategies, and relapse among schizophrenia patients at the psychiatric hospital of Oujda, Morocco. [PDF]

Pan Afr Med J
El Jabiry SE, Bouazzaoui MA, Barrimi M, Elghazouani F, Oneib B.   +4 more
europepmc   +1 more source

The Effectiveness of Positive Psychology Based Intervention on Anhedonia, and Internalized Stigma among Schizophrenic Patients

Hanaa Abd el hameed Radwan, Nehal Sobhy Emaraa, Elham Ramzy Elfiky   +2 more
openalex   +1 more source

Diagnostic validity of Addictions Neuroclinical Assessment indices for alcohol use disorder: Findings from an observational case–control study

Addiction, EarlyView.
Abstract Background and aims The Addictions Neuroclinical Assessment (ANA) provides a framework for assessing alcohol use disorder (AUD) with indices that may be both mechanistically and diagnostically informative. This study evaluated an array of measures from the three ANA domains in relation to AUD diagnostic status. Design This cross‐sectional case–
Molly L. Garber, Carly McIntyre‐Wood, Mahmoud Elsayed, Michael T. Amlung, Lawrence H. Sweet, James MacKillop   +5 more
wiley   +1 more source

Art in the abyss: creativity and the schizophrenic mind. [PDF]

Front Psychiatry
T S S, Raj G, Kiso K, Kharmih D, Yepthomi K, Kumar Gupta S, Thou G, Ashok S, T L A, Maria Benno A.   +9 more
europepmc   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source